MarketCap
Facebook
X
TelegramQuarterly report 2023-Q3
added 11-22-2023
NantHealth DPO Ratio 2011-2026 | NH
Annual DPO Ratio NantHealth
| 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 86.1 | 54.6 | 32.6 | 37.5 | 13.6 | 27.8 | 33.9 | 67.6 | - | - | - | - |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 86.1 | 13.6 | 44.2 |
Quarterly DPO Ratio NantHealth
| 2023-Q3 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| - | 143 | - | 40.9 | - | 54 | - | 29.3 | 25.5 | 43.5 | - | 62.2 | 63.9 | 53.9 | 34.5 | 36.8 | 31.4 | 20.3 | 13.2 | 13.4 | 14.2 | 19.8 | 32.5 | 25.2 | 29.9 | 36.5 | 50.6 | 58 | 27.6 | 46.1 | - | 48.7 | 46.7 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 143 | 13.2 | 40.8 |
DPO Ratio of other stocks in the Health information services industry
| Issuer | DPO Ratio | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
Accolade
ACCD
|
14.4 | - | 0.29 % | $ 206 M |  USA |
 |
Cerner Corporation
CERN
|
103 | - | - | $ 27.9 B | USA |
 |
Computer Programs and Systems
CPSI
|
17.8 | - | 4.4 % | $ 133 M | USA |
 |
Covetrus
CVET
|
41.9 | - | - | $ 2.94 B | USA |
 |
Castlight Health, Inc.
CSLT
|
36.1 | - | -7.28 % | $ 227 M | USA |
 |
HMS Holdings Corp.
HMSY
|
11.7 | - | - | $ 3.29 B | USA |
 |
Inovalon Holdings, Inc.
INOV
|
115 | - | - | $ 6.37 B | USA |
 |
iCAD
ICAD
|
112 | - | - | $ 102 M | USA |
 |
Evolent Health
EVH
|
27 | $ 2.78 | 10.56 % | $ 260 M | USA |
 |
Allscripts Healthcare Solutions
MDRX
|
10.9 | - | -10.39 % | $ 886 M | USA |
 |
GoodRx Holdings
GDRX
|
191 | $ 2.29 | 2.47 % | $ 883 M | USA |
 |
MTBC
MTBC
|
36.4 | - | -0.58 % | $ 51.7 M | USA |
 |
Akerna Corp.
KERN
|
5.62 | - | - | $ 161 M | USA |
 |
NextGen Healthcare
NXGN
|
14.5 | - | - | $ 1.6 B | USA |
 |
10x Genomics
TXG
|
32.5 | $ 25.1 | 1.21 % | $ 2.94 B | USA |
 |
OptimizeRx Corporation
OPRX
|
24.1 | $ 6.24 | 3.14 % | $ 107 M | USA |
 |
1Life Healthcare
ONEM
|
18 | - | - | $ 3.37 B | USA |
 |
Health Catalyst
HCAT
|
23.8 | $ 1.22 | 8.48 % | $ 85.3 M | USA |
 |
HealthEquity
HQY
|
12.1 | $ 83.33 | 2.42 % | $ 7.18 B | USA |
 |
Premier
PINC
|
28.6 | - | - | $ 2.33 B | USA |
 |
Schrödinger
SDGR
|
35.6 | $ 12.41 | 4.2 % | $ 911 M | USA |
 |
Phreesia
PHR
|
43.7 | $ 8.93 | 3.72 % | $ 533 M | USA |
 |
R1 RCM
RCM
|
5.63 | - | - | $ 3.81 B | USA |
 |
Teladoc Health
TDOC
|
19.2 | $ 5.51 | 4.96 % | $ 971 M | USA |
 |
Signify Health
SGFY
|
57.5 | - | -0.02 % | $ 7.21 B | USA |
 |
Streamline Health Solutions
STRM
|
62 | - | - | $ 21.4 M | USA |
 |
SCWorx Corp.
WORX
|
43.2 | - | - | $ 7.71 M | USA |
 |
American Well Corporation
AMWL
|
10.4 | $ 5.83 | 6.87 % | $ 93.6 M | USA |
 |
Tabula Rasa HealthCare
TRHC
|
22.2 | - | - | $ 255 M | USA |
 |
HealthStream
HSTM
|
26.3 | $ 20.68 | 1.68 % | $ 628 M | USA |
 |
Omnicell
OMCL
|
27.6 | $ 36.69 | 0.99 % | $ 1.69 B | USA |
 |
Progyny
PGNY
|
171 | $ 17.33 | 0.93 % | $ 1.49 B | USA |
 |
Veeva Systems
VEEV
|
15.9 | $ 166.03 | 4.39 % | $ 27.2 B | USA |
 |
Zhongchao
ZCMD
|
31 | $ 1.95 | -0.51 % | $ 6.67 M |  China |